Designer Vaccine 

When profit-driven manufacturers would be launching a range of vaccines that aim to target specific Covid-19 variants, with varying pricing based on their infectivity, transmissivity, and mortality rates—for example, the vaccine for the more transmissible Omicron variant may cost less than the vaccine for the deadlier Delta variant.

With current booster shots proving to be semi-effective against Covid-19, manufacturers’ next creative move is to come up with designer vaccines to further boost their profitability.

Designer Vaccine by MathPlus January 25, 2022